Summery_2018_06

According to the Digest`s Editorial office opinion, the main events of the June 2018 in Russian pharmaceutical industry are:

- the Federal Antimonopoly service has suspected the Ministry of health of collusion with the largest private Russian pharmaceutical company;

- a large retail chain is considering to buy a Federal pharmaceutical distributor;

- The Federal Antimonopoly service has achieved a price reduction for a number AstraZeneca medicines;

- Veronika Skvortsova topped the anti-rating of Russians trust among Ministers;

- the experiment on the total drugs labeling in Russia can be postponed for a year.

These, as well as all other industry month news, are in the June 2018 issue of the Digest.

Best regards,

Andrei Egorov, Editor-in-Chief

01.07.2018.